Next Article in Journal
Antifungal Properties of Chenopodium ambrosioides Essential Oil Against Candida Species
Previous Article in Journal
Antidepressants and Suicide Risk: A Comprehensive Overview
Open AccessReview

Antiepileptic Drug Discovery and Development: What Have We Learned and Where Are We Going?

Icagen, Inc., 4222 Emperor Blvd, Durham, NC 27703, USA
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(9), 2884-2899; https://doi.org/10.3390/ph3092884
Received: 19 August 2010 / Revised: 25 August 2010 / Accepted: 1 September 2010 / Published: 1 September 2010
Current marketed antiepileptic drugs (AEDs) consist of a variety of structural classes with different mechanisms of action. These agents typically have non-overlapping efficacy and side-effect profiles presenting multiple treatment options for the patient population. However, approximately 30% of seizure sufferers fail to respond to current therapies often because poorly tolerated side-effects limit adequate dosing. The scope of this review is to summarize selected advances in 2nd and 3rd generation AEDs as well as compounds in development with novel mechanisms of action. View Full-Text
Keywords: epilepsy; antiepileptic; AED; seizure; anticonvulsant epilepsy; antiepileptic; AED; seizure; anticonvulsant
Show Figures

Graphical abstract

MDPI and ACS Style

Gerlach, A.C.; Krajewski, J.L. Antiepileptic Drug Discovery and Development: What Have We Learned and Where Are We Going? Pharmaceuticals 2010, 3, 2884-2899.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop